Green Cross
Green Cross Corporation engages in the development and sale of pharmaceutical products in South Korea. It primarily manufactures blood derivatives, including various plasma fractions, such as immunoglobulin, antihemophilic factor, antithrombin, and tetanus immunoglobulin; vaccines; diagnostic reagents; prescription drugs; and over the counter drugs, including cataplasms, roborants, and digestive products. The company was formerly known as Green Cross Sang-A and changed its name to Green Cross Corporation in 2004. Green Cross was founded in 1967 and is headquartered in Yongin, South Korea.
Milestones
Videos
Screenshots
Above: Green Cross Screenshot -- #1
Uploaded: 9/29/09
Sources
-
PharmAbcine Closes USD $6 Million Series A Financing (bio-medicine.org)
[edit]
